Reduced levels of DEAD-box proteins DBP-RB and p72 in fetal Down syndrome brains

Neurochemical Research

Volumn 27, Issue 10, 2002, Pages 1141-1146

  Kircher, Susanne G ^a   Kim, Seong Hwan ^a   Fountoulakis, Michael ^b   Lubec, Gert ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

Brain; DEAD box protein; Down syndrome; Fetus; Helicases

Indexed keywords

COMPLEMENTARY DNA; DEAD BOX PROTEIN; HELICASE; RNA; UNCLASSIFIED DRUG;

ARTICLE; BRAIN DEVELOPMENT; BRAIN TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN SYNDROME; FEMALE; FETUS; FETUS DEVELOPMENT; HUMAN; HUMAN TISSUE; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MENTAL DEFICIENCY; PRIORITY JOURNAL; PROTEIN CONTENT; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ADENOSINE TRIPHOSPHATASES; BRAIN; CARRIER PROTEINS; DEAD-BOX RNA HELICASES; DNA HELICASES; DOWN SYNDROME; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; FETUS; HUMANS; MALE; REFERENCE VALUES; RNA HELICASES; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 0036808714     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020921324871     Document Type: Article

References (40)

1. De la Monte, S. M. 1999. Molecular abnormalities of the brain in Down syndrome: Relevance to Alzheimer's neurodegeneration. Pages 161-177, in Lubec, G. (ed.), The Molecular Biology of Down Syndrome, Springer, Wien-New York.
2. Epstein, C. J. 1995. Down syndrome (Trisomy 21). Pages 749-794, in Scriver, C. R., Beaudet, A. L., Sly, W. S., and Valle, D. (eds.), The Metabolic and Molecular Basis of Inherited Disease, McGraw-Hill, New York.
3. Wisniewki, K. E. 1990. Down syndrome children often have brain with maturation delay, retardation of growth, and cortical dysgenesis. Am. J. Med. Genet. Suppl. 7:274-281.
4. Schmidt-Sidor, B., Wisniewski, K. E., Shepard, T. H., and Sersen, A. 1990. Brain growth in Down syndrome subjects 15 to 22 weeks of gestational age and birth to 60 months. Clin. Neuropathol. 9:181-190.
5. Freidl, M., Gulesserian, T., Lubec, G., Fountoulakis, M., and Lubec, B. 2001. Deterioration of the transcriptional, splicing and elongation machinery in brain of fetal Down Syndrome J. Neural. Transm. Suppl. 61:47-58.
6. Labudova, O., Krapfenbauer, K., Moenkemann, H., Rink, H., Kitzmüller, E., and Cairns, N. 1998. Decreased transcription factor junD in brains of patients with Down Syndrome. Neurosci. Lett. 252:159-162.
7. Lubec, G., Nonaka, M., Krapfenbauer, K., Gratzer, M., Cairns, N., and Fountoulakis, M. 1999. Expression of the dihydropyrimidinase related protein 2 (DRP-2) in Down syndrome and Alzheimer's disease brain is downregulated at the mRNA and dysregulated at the protein level. Pages 161-177, in Lubec, G. (ed.), The Molecular Biology of Down Syndrome, Springer, Wien-New York.
8. Greber-Platzer, S., Schatzmann-Turhani, D., Cairns, N., Balcz, B., and Lubec, G. 1999. Expression of the transcription factor ETS2 in brain of patients with Down syndrome - Evidence against the overexpression-gene dosage hypothesis. J. Neural. Transm. Suppl. 57:269-282.
9. Greber-Platzer, S., Schatzmann-Turhani, D., Wollenek, G., and Lubec, G. 1999. Evidence against the current hypothesis of "gene dosage effects" of trisomy 21: Ets-2, encoded on chromosome 21 is not overexpressed in hearts of patients with Down syndrome. Biochem. Biophys. Res. Comm. 254:395-399.
10. Linder, P., Lasko, P. F., Ashburner, M., Leroy, P., Nielsen, P. J., and Nishi, K. 1989. Birth of the D-E-A-D box. Nature 337:121-122.
11. Heinlein, U. A. O. 1998. DEAD box for the living. J. Pathol. 184:345-347.
12. De la Cruz, J., Kressler, D., and Linder, P. 1999. Unwinding RNA in Saccharomyces cerevisiae: DEAD-box proteins and related families. TIBS 24:192-198.
13. Sowden, J., Putt, W., Morrison, K., Beddington, R., and Edwards, Y. 1995. The embryonic RNA helicase gene (ERH): A new member of the DEAD box family of RNA helicases. Biochem. J. 308:839-846.
14. Lamm, G. M., Nicol, S. M., Fuller-Pace, F. V., and Lamond, A. I. 1996. P72: A human nuclear DEAD box protein highly related to p68. Nucleic Acids Res. 24:3739-3747.
15. Stevenson, R. J., Hamilton, S. J., MacCallum, D. E., Hall, P. A., and Fuller-Pace, F. V. 1998. Expression of the 'DEAD box' RNA helicase p68 is developmentally and growth regulated and correlates with organ differentiation/maturation in the fetus. J. Pathol. 184:351-359.
16. Ip, F. C. F., Chung, S. S. K., Fu, W.-Y., and Ip, N. Y. 2000. Developmental and tissue-specific expression of DEAD box protein p72. Neuroreport 11:457-462.
17. George, R. E., Kenyon, R. M., McGuckin, A. G., Malcolm, A. J., Pearson, A. D. J., and Lunec, J. 1996. Investigation of coamplification of the candidate genes ornithine decarboxylase, ribonucleotide reductase, syndecan-1 and a DEAD box gene, DDX1, with N-myc in neuroblastoma. Oncogene 12:1583-1587.
18. Kuroda, H., White, P. S., Sulman, E. P., Manohar, C. F., Reiter, J. L., and Cohn, S. L. 1996. Physical mapping of the DDX1 gene to 340 kb 5′ of MYCN. Oncogene 13:1561-1565.
19. Manohar, C. F., Salwen, H. R., Brodeur, G. M., and Cohn, S. L. 1995. Co-amplification and concomitant high levels of expression of a DEAD box gene with MYCN in human neuroblastoma. Genes Chromosom. Cancer 14:196-203.
20. Godbout, R., Packer, M., and Bie, W. 1998. Overexpression of a DEAD box protein DDXI in neuroblastoma and retinoblastoma cell lines. J. Biol. Chem. 273:21161-21168.
21. Chuang, R.-Y., Weaver, P. L., Liu, Z., and Chang, T.-H. 1997. Requirement of the DEAD-box protein Dedlp for messenger RNA translation. Science 275:1468-1471.
22. Lahn, B. T. and Page, D. C. 1997. Functional coherence of the human Y chromosome. Science 278:675-680.
23. Qiu, X.-B., Lin, Y.-L., Thome, K. C., Pian, P., Schlegel, B. P., and Weremowicz, S. 1998. An eukaryotic RuvB-like protein (RUVBL1) essential for growth. J. Biol. Chem. 273:27786-27793.
24. Kanemaki, M., Kurokawa, Y., Matsu-ura, T., Makino, Y., Masani, A., and Okazaki, K.-I. 1999. TIP49b, a new RuvB-like DNA helicase, is included in a complex together with another RuvB-like DNA helicase, TIP49a. J. Biol. Chem. 274:22437-22444.
25. Bradford, M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
26. Langen, H., Roder, D., Juranville, J., and Fountoulakis, M. 1997. Effect of protein application mode and acrylamide concentration on the resolution of protein spots separated by two-dimensional gel electrophoresis. Electrophoresis 18:2085-2090.
27. Fountoulakis, M. and Langen, H. 1997. Identification of proteins by matrix-assisted laser desorption ionisation-mass spectroscopy following in-gel digestion in low-salt nonvolatile buffer and simplified peptide recovery. Anal. Biochem. 250:153-156.
28. Berndt, P., Hobolm, U., and Langen, H. 1999. Reliable automatic protein identification from matrix-assisted laser desorption/ionisation mass spectrometric peptide fingerprints. Electrophoresis 20:3521-3526.
29. Wassarman, D. A. and Steitz, J. A. 1991. Alive with DEAD proteins. Nature 349:463-464.
30. Schwer, B. and Guthrie, C. 1991. PRP16 is an RNA-dependent ATPase that interacts transiently with the spliceosome. Nature 349:494-499.
31. Iost, I. and Dreyfus, M. 1994. mRNAs can be stabilized by DEAD-box proteins. Nature 372:193-196.
32. Burd, C. G. and Dreyfuss, G. 1994. Conserved structures and diversity of functions of RNA-binding proteins. Science 265: 615-621.
33. Weitzdörfer, R., Fountoulakis, M., and Lubec, G. 2001. Aberrant expression of dihydropyriminidase related proteins 2, 3 and 4 in fetal Down syndrome brain. Pages 71-82, in Lubec, G. (ed.), Protein Expression in Down Syndrome Brain, Springer, Wien-New York.
34. Jensen, R. D. and Miller, R. W. 1971. Retinoblastoma: Epidemiologic characteristics. N. Engl. J. Med. 285:307-311.
35. Hasle, H. and Clemmensen, I. C. H. 2000. Incidence of cancer in individuals with Down syndrome. Tidsskr. Nor Laegeforen 120:2878-2881.
36. Satge, D., Sasco, A. J., Carlsen, N. L. T., Stiller, C. A., Rubie, H., and Hero, B. 1998. A lack of neuroblastoma in Down syndrome: A study from II European countries. Cancer Res. 58:448-452.
37. Barger, S. W., Van Eldik, L. J., and Mattson, M. P. 1995. S100 beta protects hippocampal neurons from damage induced by glucose deprivation. Brain Res. 677:167-170.
38. Satge, D., Sasco, A. J., Carlsen, N. L. T., Rubie, H., and Stiller, C. A. 1997. A negative association between Down's syndrome and neuroblastoma. Arch. Dis. Child. 76:80.
39. Godbout, R. and Squire, J. 1993. Amplification of a DEAD box protein gene in retinoblastoma cell lines. Proc. Natl. Acad. Sci. U S A 90:7578-7582.
40. Makino, Y., Kanemaki, M., Kurokawa, Y., Koji, T. and Tamura, T.-A. 1999. A rat RuvB-like protein, TIP49a, is a germ cell-enriched novel DNA helicase. J. Biol. Chem. 274:15329-15335.